Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
167.49
0.95 (0.57%)
At close: Sep 04, 2025, 12:14 PM
Evomela Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.47M | -516K | -26.05% |
| Mar 31, 2025 | 1.98M | -6.31M | -76.10% |
| Dec 31, 2024 | 8.29M | 6.54M | +374.36% |
| Sep 30, 2024 | 1.75M | -986K | -36.08% |
| Jun 30, 2024 | 2.73M | 1.34M | +95.63% |
| Mar 31, 2024 | 1.4M | -2.52M | -64.38% |
| Dec 31, 2023 | 3.92M | 1.43M | +57.07% |
| Sep 30, 2023 | 2.5M | 140K | +5.94% |
| Jun 30, 2023 | 2.36M | -193K | -7.57% |
| Mar 31, 2023 | 2.55M | -24.33M | -90.51% |
| Dec 31, 2022 | 26.88M | 23.76M | +760.68% |
| Sep 30, 2022 | 3.12M | 729K | +30.45% |
| Jun 30, 2022 | 2.39M | -307K | -11.37% |
| Mar 31, 2022 | 2.7M | -32.67M | -92.36% |
| Dec 31, 2021 | 35.38M | 32.71M | +1227.43% |
| Sep 30, 2021 | 2.67M | 472K | +21.52% |
| Jun 30, 2021 | 2.19M | -140K | -6.00% |
| Mar 31, 2021 | 2.33M | -84.24M | -97.31% |
| Dec 31, 2020 | 86.57M | 84.77M | +4704.11% |
| Sep 30, 2020 | 1.8M | 603K | +50.29% |
| Jun 30, 2020 | 1.2M | -377K | -23.92% |
| Mar 31, 2020 | 1.58M | -6.04M | -79.30% |
| Jun 30, 2018 | 7.61M | -13.19M | -63.40% |
| Mar 31, 2018 | 20.8M | n/a | n/a |